Specialties – Page 70

Cutaneous Presentation of Hyperthyroidism in a Middle-aged Female: A Case Report

By MedXY 09/28/2025

A 45-year-old female presented with pruritic skin lesions and weight loss, diagnosed with hyperthyroidism manifesting cutaneous symptoms. Treatment with antithyroid medication led to symptom resolution.

OB/GYN & Women's Health Oncology Specialties

Evolving Trends and Economic Implications of Breast Cancer Screening in Older US Women: Navigating Value and Cost

By MedXY 09/28/2025

Breast cancer screening among older US women shows stable use but rising costs driven by low-value technologies; optimizing screening strategies could enhance value and reduce expenditure.

General Surgery

Cutting through the p-value: Assessing Clinical Relevance in Inguinal Hernia Repair Surgical Literature

By MedXY 09/28/2025

This analysis reveals pervasive underreporting of clinical relevance thresholds in studies comparing open, laparoscopic, and robotic inguinal hernia repairs, urging a shift beyond p-values to improve evidence-based surgical decisions.

Clinical Updates Dermatology news

Australian Dermatologists’ Perspectives on AI Integration: Trust, Benefits, and Barriers in Clinical Practice

By MedXY 09/28/2025

A recent survey reveals that Australian dermatologists are cautiously integrating AI into practice, prioritizing accuracy and trust for diagnostic use, with optimism about AI enhancing patient access and reducing workload but concerns about data transparency and corporate influence.

Dermatology Family Medicine & Nutrition Specialties

Mediterranean Diet as Adjunct Therapy in Psoriasis: Insights from the MEDIPSO Randomized Clinical Trial

By MedXY 09/28/2025

A 16-week Mediterranean diet intervention significantly reduced psoriasis severity and improved metabolic markers in patients with mild to moderate disease, suggesting diet’s role as adjunctive therapy in psoriasis management.

Critical Care Emergency Medicine news Specialties

Enhancing Communication in Trauma ICUs with the Best Case/Worst Case Tool: A Feasible Approach to Improve Prognostic Discussions

By MedXY 09/28/2025

The Best Case/Worst Case-ICU communication tool supports trauma ICU teams in effectively discussing prognoses with families, improving decision-making and reducing distress, though implementation faces practical barriers.

news Pediatrics Specialties

Progression of Transdiagnostic Clinical Stages From Childhood to Young Adulthood: Evidence and Implications

By MedXY 09/28/2025

This review synthesizes cohort and longitudinal studies supporting the progression of transdiagnostic mental health stages from familial risk in childhood through early symptoms in adolescence to clinically significant disorders in young adulthood, independent of early life confounders.

news Oncology Specialties

Painful Sunburns and Their Link to Cutaneous Squamous Cell Carcinoma: Insights from a Comprehensive Meta-Analysis

By MedXY 09/28/2025

A meta-analysis of over 320,000 participants confirms that painful, blistering sunburns, especially in childhood, significantly increase the risk of cutaneous squamous cell carcinoma (cSCC).

Family Medicine & Nutrition Psychiatry Specialties

Soft Drink Consumption and Depression: The Gut Microbiome Connection, Especially Eggerthella

By MedXY 09/28/2025

This analysis explores how soft drink consumption correlates with major depressive disorder (MDD), revealing gut microbiome alterations—particularly in Eggerthella abundance—that may mediate this association, highlighting potential intervention targets.

news Public Health Specialties

Effective Communication of Medical Numerical Information: Guidelines for Researchers

By MedXY 09/28/2025

This article outlines recommended guidelines for researchers reporting studies on communicating health-related numbers to lay audiences, highlighting common reporting issues and proposing seven key recommendations to improve clarity and synthesis of evidence.

news Pediatrics Public Health Specialties

Navigating Childhood Insurance in the US: Insights into Medicaid, CHIP, and Uninsurance Dynamics

By MedXY 09/28/2025

A simulation study reveals that 75% of US children experience publicly subsidized insurance or uninsurance periods by age 18, highlighting the impact of state Medicaid policies on pediatric coverage gaps.

Clinical Updates Neurology news

Clinically Meaningful Changes in Cognitive and Functional Measures Early in Alzheimer’s Disease: Insights from Population-Based Cohorts

By MedXY 09/28/2025

This review synthesizes evidence on clinically meaningful within-patient changes in cognitive and functional assessments among individuals transitioning to mild cognitive impairment (MCI), highlighting implications for clinical trials and early intervention in Alzheimer's disease and related dementias (ADRD).

Ophthalmology Pediatrics Specialties

Understanding Patient Acceptance of Complement Inhibitor Therapy in Geographic Atrophy

By MedXY 09/28/2025

A UK study reveals most patients with geographic atrophy are open to intravitreal complement inhibitor injections if these treatments offer vision improvement, highlighting the vital role of functional benefits in therapy acceptance.

Clinical Updates Ophthalmology Pediatrics Specialties

Atropine vs Cyclopentolate: Optimizing Premyopia Diagnosis in Preschool Children

By MedXY 09/28/2025

This study compares atropine and cyclopentolate for cycloplegia in preschoolers, finding atropine leads to less myopic refraction and may reduce premyopia overestimation. It highlights implications for precise refractive diagnosis in young children.

AI news Oncology Radiology Specialties

Advancing Precision Medicine in Hepatocellular Carcinoma: Machine Learning Radiomic Models Surpass Clinical Biomarkers in Predicting Immunotherapy Outcomes

By MedXY 09/27/2025

Integrated radiomic-clinical machine learning models outperform traditional clinical biomarkers in predicting survival and treatment response in unresectable hepatocellular carcinoma patients undergoing atezolizumab plus bevacizumab therapy.

Cardiology Clinical Updates Nephrology

Exploring the Impact of Reduced Left Ventricular Function on Outcomes After PCI in Chronic Kidney Disease Patients

By MedXY 09/27/2025

Reduced left ventricular ejection fraction (LVEF) adversely affects survival and myocardial infarction risk in patients with chronic kidney disease undergoing percutaneous coronary intervention, despite no significant difference in overall major cardiovascular events.

Cardiology Clinical Updates General Surgery Pathology & Lab Medicine Specialties

Circulating Trimethylamine N-Oxide: A Novel Biomarker for Predicting Abdominal Aortic Aneurysm Progression and Surgical Risk

By MedXY 09/27/2025

Elevated plasma TMAO levels are associated with higher risk of abdominal aortic aneurysm development, rapid aneurysm growth, and need for surgical repair, providing a promising tool for risk stratification and personalized surveillance.

AI Cardiology Specialties

Harnessing Artificial Intelligence for Enhanced Prediction of Complete Heart Block Risk via Electrocardiography

By MedXY 09/27/2025

AIRE-CHB, a novel AI-enhanced ECG model, significantly improves prediction of incident complete heart block, outperforming traditional bifascicular block assessment and offering promising clinical utility in risk stratification and management.

Cardiology news

Long-Term Survival Outcomes After Initial Stress Testing Versus Coronary CTA in Suspected CAD: Insights from the PROMISE Trial

By MedXY 09/27/2025

The PROMISE trial's 10-year follow-up shows no difference in all-cause or cardiovascular mortality between initial functional stress testing and anatomic coronary CTA in symptomatic patients with suspected coronary artery disease.

Cardiology

Sustained Benefits of Physiology-Guided Complete Revascularization in Elderly Myocardial Infarction Patients: Insights from the FIRE Trial Three-Year Follow-Up

By MedXY 09/27/2025

The FIRE randomized clinical trial demonstrates that physiology-guided complete revascularization in patients aged 75 and older with myocardial infarction and multivessel disease maintains significant reductions in death, MI, stroke, and heart failure hospitalizations over a three-year follow-up, outperforming culprit-only treatment.